SB 592

  • Virginia Senate Bill
  • 2025 Regular Session
  • Introduced in Senate Jan 10, 2024
  • Senate
  • House
  • Governor

Preferred Drug List/Common Core Formulary; approval of a nonpreferred drug.

Abstract

Department of Medical Assistance Services; Preferred Drug List/Common Core Formulary; approval of a nonpreferred drug. Directs the Department of Medical Assistance Services to eliminate the requirement that a patient try and fail a drug from the Preferred Drug List/Common Core Formulary in the six months immediately prior to approval of a nonpreferred drug when such patient has previously tried the drug from the Preferred Drug List/Common Core Formulary and experienced harmful side effects.

A BILL to direct the Department of Medical Assistance Services to eliminate the requirement that a patient try and fail a drug from the Preferred Drug List/Common Core Formulary before approval of a nonpreferred drug in certain circumstances. 24103030D

Bill Sponsors (1)

Votes


Actions


Nov 19, 2024

Senate

Left in Education and Health

Feb 08, 2024

Senate

Continued to 2025 in Education and Health (15-Y 0-N)

Feb 05, 2024

Senate

Assigned Education and Health Sub: Health

Jan 24, 2024

Senate

Impact statement from DPB (SB592)

Jan 10, 2024

Senate

Prefiled and ordered printed; offered 01/10/24 24103030D

Senate

Referred to Committee on Education and Health

Bill Text

Bill Text Versions Format
Introduced HTML PDF

Related Documents

Document Format
Impact statement from DPB (SB592) PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.